Les Laboratoires Servier SAS - Company Profile
Powered by 
All the data and insights you need on Les Laboratoires Servier SAS in one report.
$295
- Save hours of research time and resources with
our up-to-date Les Laboratoires Servier SAS Strategy Report
- Understand Les Laboratoires Servier SAS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Les Laboratoires Servier SAS Clinical Trials
Determine Les Laboratoires Servier SAS go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Les Laboratoires Servier SAS Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover Oral Bioequivalence Study Comparing Gliclazide and Metformin Extended Release Tablets 60 Mg / 500 Mg Manufactured by Servier India Private Limited with Glycinorm M Od (Gliclazide Modified Release and Metformin Extended Release Tablets 60 Mg / 500 Mg) Tablets (Indian Innovator) Manufactured by IPCA Laboratories, India in Healthy, Adult, Human Male Subjects under Fasting Conditions | GDCT0478778 | (gliclazide + metformin hydrochloride) ER | Metabolic Disorders | Type 2 Diabetes | Phase I | Planned | Les Laboratoires Servier SAS |
| A Study of Vorasidenib in Participants with Moderate or Mild Hepatic Impairment and Matched Participants with Normal Hepatic Function | GDCT0476027 | vorasidenib citrate | Oncology | Low-Grade Glioma; Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia; Solid Tumor | Phase I | Planned | Servier Institute of International Research |
| A Phase I First-In-Human and Healthy Volunteers Study of ODS-2005294 in Parkinson's Disease | GDCT0474518 | ODS-2005294 | Central Nervous System | Parkinson's Disease | Phase I | Planned | Les Laboratoires Servier SAS |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer